These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 15012621)

  • 41. High serum prostate-specific antigen concentrations in hirsute women do not decrease with treatment by the combination of spironolactone and the contraceptive pill.
    Guzelmeric K; Seker N; Unal O; Turan C
    Gynecol Endocrinol; 2004 Oct; 19(4):190-5. PubMed ID: 15724801
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Peripheral androgen blockade versus glandular androgen suppression in the treatment of hirsutism.
    Carmina E; Lobo RA
    Obstet Gynecol; 1991 Nov; 78(5 Pt 1):845-9. PubMed ID: 1833685
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of finasteride, a 5 alpha-reductase inhibitor, on circulating androgens and gonadotropin secretion in hirsute women.
    Fruzzetti F; de Lorenzo D; Parrini D; Ricci C
    J Clin Endocrinol Metab; 1994 Sep; 79(3):831-5. PubMed ID: 8077369
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Recurrence rate of hirsutism after 3 different antiandrogen therapies.
    Yücelten D; Erenus M; Gürbüz O; Durmuşoğlu F
    J Am Acad Dermatol; 1999 Jul; 41(1):64-8. PubMed ID: 10411413
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of hirsutism: comparisons between different antiandrogens with central and peripheral effects.
    Fruzzetti F; Bersi C; Parrini D; Ricci C; Genazzani AR
    Fertil Steril; 1999 Mar; 71(3):445-51. PubMed ID: 10065780
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Spironolactone in combination drug therapy for unresponsive hirsutism.
    Pittaway DE; Maxson WS; Wentz AC
    Fertil Steril; 1985 Jun; 43(6):878-82. PubMed ID: 3158552
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Short term effects of spironolactone on blood lipid profile: a 3-month study on a cohort of young women with hirsutism.
    Nakhjavani M; Hamidi S; Esteghamati A; Abbasi M; Nosratian-Jahromi S; Pasalar P
    Br J Clin Pharmacol; 2009 Oct; 68(4):634-7. PubMed ID: 19843067
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Treatment of hirsutism with spironolactone.
    Tremblay RR
    Clin Endocrinol Metab; 1986 May; 15(2):363-71. PubMed ID: 2941190
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Improved efficacy of low-dose spironolactone and metformin combination than either drug alone in the management of women with polycystic ovary syndrome (PCOS): a six-month, open-label randomized study.
    Ganie MA; Khurana ML; Nisar S; Shah PA; Shah ZA; Kulshrestha B; Gupta N; Zargar MA; Wani TA; Mudasir S; Mir FA; Taing S
    J Clin Endocrinol Metab; 2013 Sep; 98(9):3599-607. PubMed ID: 23846820
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Do Pleiotropic Effects of Spironolactone in Women with PCOS Make it More than an Anti-androgen? Evidence from a Systematic Review and Meta-analysis.
    Bashir R; Asrar MM; Shah IA; Wani IA; Ganie MA
    Curr Pharm Des; 2023; 29(19):1486-1496. PubMed ID: 36999713
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The effects of spironolactone on testosterone fractions and sex-hormone binding globulin binding capacity in hirsute women.
    Marcondes JA; Minanni SL; Luthold WW; Lerário AC; Nery M; Mendonça BB; Wajchenberg BL; Kirschner MA
    J Endocrinol Invest; 1995 Jun; 18(6):431-5. PubMed ID: 7594237
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Comparison of Diane 35 and Diane 35 plus finasteride in the treatment of hirsutism.
    Tartagni M; Schonauer LM; De Salvia MA; Cicinelli E; De Pergola G; D'Addario V
    Fertil Steril; 2000 Apr; 73(4):718-23. PubMed ID: 10731531
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Spironolactone versus placebo or in combination with steroids for hirsutism and/or acne.
    Farquhar C; Lee O; Toomath R; Jepson R
    Cochrane Database Syst Rev; 2001; (4):CD000194. PubMed ID: 11687072
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Antiandrogen drugs lower serum prostate-specific antigen (PSA) levels in hirsute subjects: evidence that serum PSA is a marker of androgen action in women.
    Negri C; Tosi F; Dorizzi R; Fortunato A; Spiazzi GG; Muggeo M; Castello R; Moghetti P
    J Clin Endocrinol Metab; 2000 Jan; 85(1):81-4. PubMed ID: 10634368
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Spironolactone and estrogen-progestin therapy for hirsutism.
    Board JA; Rosenberg SM; Smeltzer JS
    South Med J; 1987 Apr; 80(4):483-6. PubMed ID: 3563583
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical efficacy of lower dose flutamide 125 mg/day in the treatment of hirsutism.
    Müderris II; Bayram F
    J Endocrinol Invest; 1999 Mar; 22(3):165-8. PubMed ID: 10219882
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Relative safety and efficacy of finasteride for treatment of hirsutism.
    Townsend KA; Marlowe KF
    Ann Pharmacother; 2004 Jun; 38(6):1070-3. PubMed ID: 15100391
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-Term Response of Hirsutism and Other Hyperandrogenic Symptoms to Combination Therapy in Polycystic Ovary Syndrome.
    Ezeh U; Huang A; Landay M; Azziz R
    J Womens Health (Larchmt); 2018 Jul; 27(7):892-902. PubMed ID: 29878857
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bone mineral density in women with idiopathic hirsutism.
    Gregoriou O; Kouskouni E; Bakas P; Konidaris S; Papadias K; Kalovidouris A; Creatsas G
    Gynecol Endocrinol; 2000 Oct; 14(5):364-8. PubMed ID: 11109975
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The grade of hirsutism correlated to serum androgen levels and hormonal indices.
    Ruutiainen K; Erkkola R; Kaihola HL; Santti R; Irjala K
    Acta Obstet Gynecol Scand; 1985; 64(8):629-33. PubMed ID: 2938400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.